Cargando…

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

BACKGROUND: Candidiasis is commonly observed in patients with primary sclerosing cholangitis (PSC), but the clinical risk factors associated with its presence have not been fully investigated. In this study, we aimed to analyse the incidence, risk factors, and transplantation-free survival in primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupp, Christian, Bode, Konrad Alexander, Chahoud, Fadi, Wannhoff, Andreas, Friedrich, Kilian, Weiss, Karl-Heinz, Sauer, Peter, Stremmel, Wolfgang, Gotthardt, Daniel Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209225/
https://www.ncbi.nlm.nih.gov/pubmed/25338733
http://dx.doi.org/10.1186/s12879-014-0562-8
_version_ 1782341233247518720
author Rupp, Christian
Bode, Konrad Alexander
Chahoud, Fadi
Wannhoff, Andreas
Friedrich, Kilian
Weiss, Karl-Heinz
Sauer, Peter
Stremmel, Wolfgang
Gotthardt, Daniel Nils
author_facet Rupp, Christian
Bode, Konrad Alexander
Chahoud, Fadi
Wannhoff, Andreas
Friedrich, Kilian
Weiss, Karl-Heinz
Sauer, Peter
Stremmel, Wolfgang
Gotthardt, Daniel Nils
author_sort Rupp, Christian
collection PubMed
description BACKGROUND: Candidiasis is commonly observed in patients with primary sclerosing cholangitis (PSC), but the clinical risk factors associated with its presence have not been fully investigated. In this study, we aimed to analyse the incidence, risk factors, and transplantation-free survival in primary sclerosing cholangitis (PSC) patients with persistent biliary candidiasis. METHODS: We retrospectively analysed patients diagnosed with PSC who were admitted to our department during 2002 to 2012. One-hundred fifty patients whose bile cultures were tested for fungal species were selected, and their clinical and laboratory parameters were investigated. The results of endoscopic retrograde cholangiography (ERC) and bile cultures were analysed using chart reviews. The cases of biliary candidiasis were sub-classified as transient or persistent. RESULTS: Thirty out of 150 (20.0%) patients had biliary candidiasis. Although all patients demonstrated comparable baseline characteristics, those with biliary candidiasis showed significantly reduced transplantation-free survival (p < 0.0001) along with a markedly elevated frequency of cholangiocarcinoma (CCA) (p = 0.04). The patients were further sub-classified according to the transient (15/30) or persistent (15/30) nature of their biliary candidiasis. A subgroup analysis showed reduced survival with a greater necessity for orthotopic liver transplantation (OLT) only in patients with persistence of Candida (p = 0.007). The survival in the patients with transient biliary candidiasis was comparable to that in candidiasis-free patients. In a multivariate regression analysis that included Mayo risk score (MRS), sex, age, dominant stenosis, inflammatory bowel disease, autoimmune hepatitis overlap syndrome, and number of times ERC was performed, biliary candidiasis was an independent risk factor for reduced survival (p = 0.008). Risk factors associated with acquisition of biliary candidiasis were age at PSC diagnosis and number of ERCs. CONCLUSIONS: The persistence of biliary candidiasis is associated with markedly reduced transplantation-free survival in PSC patients. By contrast, actuarial survival in patients with transient biliary candidiasis approaches that for patients without any evidence of biliary candidiasis. Further studies on the treatment of persistent biliary candidiasis in patients with PSC are warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0562-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4209225
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42092252014-10-28 Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis Rupp, Christian Bode, Konrad Alexander Chahoud, Fadi Wannhoff, Andreas Friedrich, Kilian Weiss, Karl-Heinz Sauer, Peter Stremmel, Wolfgang Gotthardt, Daniel Nils BMC Infect Dis Research Article BACKGROUND: Candidiasis is commonly observed in patients with primary sclerosing cholangitis (PSC), but the clinical risk factors associated with its presence have not been fully investigated. In this study, we aimed to analyse the incidence, risk factors, and transplantation-free survival in primary sclerosing cholangitis (PSC) patients with persistent biliary candidiasis. METHODS: We retrospectively analysed patients diagnosed with PSC who were admitted to our department during 2002 to 2012. One-hundred fifty patients whose bile cultures were tested for fungal species were selected, and their clinical and laboratory parameters were investigated. The results of endoscopic retrograde cholangiography (ERC) and bile cultures were analysed using chart reviews. The cases of biliary candidiasis were sub-classified as transient or persistent. RESULTS: Thirty out of 150 (20.0%) patients had biliary candidiasis. Although all patients demonstrated comparable baseline characteristics, those with biliary candidiasis showed significantly reduced transplantation-free survival (p < 0.0001) along with a markedly elevated frequency of cholangiocarcinoma (CCA) (p = 0.04). The patients were further sub-classified according to the transient (15/30) or persistent (15/30) nature of their biliary candidiasis. A subgroup analysis showed reduced survival with a greater necessity for orthotopic liver transplantation (OLT) only in patients with persistence of Candida (p = 0.007). The survival in the patients with transient biliary candidiasis was comparable to that in candidiasis-free patients. In a multivariate regression analysis that included Mayo risk score (MRS), sex, age, dominant stenosis, inflammatory bowel disease, autoimmune hepatitis overlap syndrome, and number of times ERC was performed, biliary candidiasis was an independent risk factor for reduced survival (p = 0.008). Risk factors associated with acquisition of biliary candidiasis were age at PSC diagnosis and number of ERCs. CONCLUSIONS: The persistence of biliary candidiasis is associated with markedly reduced transplantation-free survival in PSC patients. By contrast, actuarial survival in patients with transient biliary candidiasis approaches that for patients without any evidence of biliary candidiasis. Further studies on the treatment of persistent biliary candidiasis in patients with PSC are warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0562-8) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-23 /pmc/articles/PMC4209225/ /pubmed/25338733 http://dx.doi.org/10.1186/s12879-014-0562-8 Text en © Rupp et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rupp, Christian
Bode, Konrad Alexander
Chahoud, Fadi
Wannhoff, Andreas
Friedrich, Kilian
Weiss, Karl-Heinz
Sauer, Peter
Stremmel, Wolfgang
Gotthardt, Daniel Nils
Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title_full Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title_fullStr Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title_full_unstemmed Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title_short Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
title_sort risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209225/
https://www.ncbi.nlm.nih.gov/pubmed/25338733
http://dx.doi.org/10.1186/s12879-014-0562-8
work_keys_str_mv AT ruppchristian riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT bodekonradalexander riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT chahoudfadi riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT wannhoffandreas riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT friedrichkilian riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT weisskarlheinz riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT sauerpeter riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT stremmelwolfgang riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis
AT gotthardtdanielnils riskfactorsandoutcomeinpatientswithprimarysclerosingcholangitiswithpersistentbiliarycandidiasis